 | |
- close
- close
|
PR Newswire
Dec 1
Comment
COLUMBIA, Md., Dec. 1 /PRNewswire-FirstCall/ -- Arbitron Inc. (NYSE: ARB) announced that it will present at the J.P. Morgan SMid Cap Conference, which will take place Wednesday, December 2nd, and Thursday, December 3rd, at the J.P. Morgan Conference
PR Newswire
Nov 30
Comment
COLUMBIA, Md., Nov. 30 /PRNewswire-FirstCall/ -- Arbitron Inc. (NYSE: ARB) announced today that leading multicultural advertising and marketing company Burrell Advertising has signed a multi-year agreement for Arbitron's RADAR® network rating
PR Newswire
Nov 18
Comment
COLUMBIA, Md., Nov. 18 /PRNewswire-FirstCall/ -- Arbitron Inc. (NYSE: ARB) today announced that its Board of Directors has approved the payment of a quarterly cash dividend of $0.10 (ten cents) per common share ($0.40 per share on an annualized
MedPage Today
Nov 17
Comment
ORLANDO (MedPage Today) -- High doses of the angiotensin receptor blocker (ARB) losartan (Cozaar) for heart failure patients who cannot tolerate an ACE inhibitor may reduce mortality and heart failure hospitalization, researchers found.
Index Universe
Nov 17
Comment
IndexIQ launched today the first exchange-traded fund to invest in global companies that are the targets of a takeover.
M&A products are not new to investors, but IndexIQ’s new offering is the first play on that space in an ETF...
StreetInsider.com
Oct 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Arbitron+%28ARB%29+Misses+Q3+EPS+by+2c%3B+Comments+on+FY+Outlook/5028375.html for the full story.
PR Newswire
Oct 20
Comment
COLUMBIA, Md., Oct. 20 /PRNewswire-FirstCall/ -- Arbitron Inc. (NYSE: ARB) today announced financial results for the third quarter ended September 30, 2009. Net income for the quarter was $13.7 million or $0.51 per share (diluted), compared with
MedPage Today
Oct 19
Comment
WASHINGTON (MedPage Today) -- The FDA has expanded the indication for the antihypertension drug telmisartan (Micardis), making it the first angiotensin receptor blocker (ARB) approved for primary prevention in patients 55 or older and high-risk...
PR Newswire
Oct 2
Comment
COLUMBIA, Md., Oct. 2 /PRNewswire-FirstCall/ -- Arbitron Inc. (NYSE: ARB) announced today its implementation strategy to increase sample sizes in its Portable People Meter(TM) (PPM(TM)) markets. The Company now plans to increase sample targets by ten
PR Newswire
Sep 30
Comment
COLUMBIA, Md., Sept. 30 /PRNewswire-FirstCall/ -- Arbitron Inc. (NYSE: ARB) announced today the formation of a Cross-Platform media measurement group and the complementary expansion of its executive management team. By establishing this group, which
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
ARB AT A GLANCE
References
| ||||||
|
|
